226 related articles for article (PubMed ID: 14990658)
1. Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia?
Styczynski J; Wysocki M
J Clin Oncol; 2004 Mar; 22(5):963-4. PubMed ID: 14990658
[No Abstract] [Full Text] [Related]
2. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
3. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
Styczynski J; Koltan A; Wysocki M
Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
[TBL] [Abstract][Full Text] [Related]
4. Acute lymphoblastic leukemia: current treatment concepts.
Arya LS
Indian Pediatr; 2000 Apr; 37(4):397-406. PubMed ID: 10781233
[No Abstract] [Full Text] [Related]
5. [Diagnostic and prognostic value of testicular biopsy in boys with acute lymphoblastic leukemia after chemotherapy].
Koehler M; Bubała H; Daszkiewicz P; Newecka-Samól T; Rodziewicz B; Rytlewska M; Skrobowska A; Sońta-Jakimczyk D; Trendowska D
Pol Tyg Lek; 1988 Dec; 43(50):1619-22. PubMed ID: 3256803
[No Abstract] [Full Text] [Related]
6. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on mitoxantrone contained regimen for treatment of newly diagnosed childhood acute lymphoblastic leukemia].
Wang WQ; Liu XY; Liu LQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):602-3. PubMed ID: 16137060
[No Abstract] [Full Text] [Related]
8. Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.
Styczynski J; Wysocki M; Dluzniewska A; Juraszewska E; Balwierz W; Czyzewski K; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Stanczak E; Malinowska I; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Kapuscinska L; Szczepanek J; Kolodziej B; Rafinska B; Kubicka M
Anticancer Res; 2008; 28(3B):1927-31. PubMed ID: 18630483
[TBL] [Abstract][Full Text] [Related]
9. Atypical pyoderma gangrenosum as a manifestation of childhood acute lymphoblastic leukemia.
Bakhshi S; Sethuraman G; Singh MK; Arya LS
Pediatr Dermatol; 2005; 22(6):543-5. PubMed ID: 16354258
[TBL] [Abstract][Full Text] [Related]
10. The childhood leukemias.
Colby-Graham MF; Chordas C
J Pediatr Nurs; 2003 Apr; 18(2):87-95. PubMed ID: 12720205
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
12. Overt testicular disease (OTD) at diagnosis is not associated with a poor prognosis in childhood acute lymphoblastic leukemia: results of the EORTC CLG Study 58881.
Sirvent N; Suciu S; Bertrand Y; Uyttebroeck A; Lescoeur B; Otten J
Pediatr Blood Cancer; 2007 Sep; 49(3):344-8. PubMed ID: 16358303
[TBL] [Abstract][Full Text] [Related]
13. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
[TBL] [Abstract][Full Text] [Related]
15. [Progress in the treatment of acute lymphoid leukemia in children. Experience of the GATLA/GLATHEM, 1967-1987].
Garay G; Aversa LA; Svarch E; Sackmann Muriel F; Drelichman G; Santarelli MT; Jiménez E; Divito JM; Pavlovsky S; Eppinger Helft M
Sangre (Barc); 1989 Apr; 34(2):136-43. PubMed ID: 2667171
[No Abstract] [Full Text] [Related]
16. Childhood acute lymphoblastic leukemia presenting with severe hepatic dysfunction.
Belgaumi AF; Hudson MM
Med Pediatr Oncol; 2001 Aug; 37(2):142-4. PubMed ID: 11496355
[No Abstract] [Full Text] [Related]
17. [21 years in the treatment of acute lymphoblastic leukemias in children (1967-1987)].
Ortega JJ; Javier G; Olivé T; Montagut JM
Sangre (Barc); 1988 Oct; 33(5):372-82. PubMed ID: 3073534
[No Abstract] [Full Text] [Related]
18. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
Plasschaert SL; Kamps WA; Vellenga E; de Vries EG; de Bont ES
Cancer Treat Rev; 2004 Feb; 30(1):37-51. PubMed ID: 14766125
[TBL] [Abstract][Full Text] [Related]
19. Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions.
Hochberg J; Cairo MS
Pediatr Blood Cancer; 2009 Dec; 53(6):917-9. PubMed ID: 19672977
[No Abstract] [Full Text] [Related]
20. In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
Lönnerholm G; Thörn I; Sundström C; Frost BM; Abrahamsson J; Behrendtz M; Heldrup J; Jacobsson S; Li A; Olofsson T; Porwit A; Söderhäll S; Larsson R; Forestier E
Leuk Res; 2009 Jan; 33(1):46-53. PubMed ID: 18639340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
